Acacia Research director granted 6,237 shares
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Gavin Molinelli received a stock grant as compensation. On March 31, 2026, he was awarded 6,237 shares of common stock at $4.81 per share in lieu of cash for his Q1 2026 director fees. After this grant, he directly holds 174,476 shares of Acacia Research common stock. This is a compensatory share award, not an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 | 6,237 | $4.81 | $30K |
Footnotes (1)
- F1. Grant of shares of Common Stock in lieu of cash for Q1 2026 director fees.
Key Figures
Key Terms
Grant, award, or other acquisition financial
in lieu of cash financial
director fees financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ACTG director Gavin Molinelli report?
Was Gavin Molinelli’s ACTG Form 4 transaction a market purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.